Arbutus Biopharma Ownership | Who Owns Arbutus Biopharma?


OverviewForecastRevenueFinancialsChartTranscripts

Arbutus Biopharma Ownership Summary


Arbutus Biopharma is owned by 16.26% institutional investors, 21.89% insiders, and 61.84% retail investors. Morgan stanley is the largest institutional shareholder, holding 11.93% of ABUS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.57% of its assets in Arbutus Biopharma shares.

ABUS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockArbutus Biopharma16.26%21.89%61.84%
SectorHealthcare Stocks 279.19%10.62%-189.81%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley20.96M11.93%$64.77M
Whitefort capital management, lp13.31M7.17%$46.44M
Blackrock funding, inc. /de12.94M6.85%$42.31M
Blackrock11.55M6.58%$35.70M
Two seas capital lp9.47M5.10%$33.04M
Vanguard group8.98M4.75%$29.37M
State street5.03M2.66%$16.44M
Geode capital management3.48M1.84%$11.39M
Foursixthree capital lp2.45M1.32%$8.55M
Blackbarn capital partners lp2.34M1.24%$7.66M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Whitefort capital management, lp13.31M21.85%$46.44M
Corbin capital partners682.49K3.64%$2.23M
Fourworld capital management1.23M2.75%$4.28M
Foursixthree capital lp2.45M2.36%$8.55M
Adar1 capital management1.88M1.22%$6.56M
Two seas capital lp9.47M1.04%$33.04M
Stempoint capital lp467.88K0.52%$1.63M
Blackbarn capital partners lp2.34M0.42%$7.66M
Saba capital management979.52K0.09%$3.42M
Quinn opportunity partners404.88K0.09%$1.32M

Top Buyers

HolderShares% AssetsChange
Morgan stanley20.96M0.01%12.13M
Foursixthree capital lp2.45M2.36%2.45M
Blackrock11.55M0.00%1.15M
Jpmorgan chase896.26K0.00%806.67K
Two seas capital lp9.47M1.04%725.00K

Top Sellers

HolderShares% AssetsChange
Adage capital partners gp1.65M0.01%-1.25M
Boothbay fund management162.28K0.01%-450.00K
Corbin capital partners682.49K3.64%-170.82K
Lmr partners llp---158.25K
Lighthouse investment partners---99.06K

New Positions

HolderShares% AssetsChangeValue
Foursixthree capital lp2.45M2.36%2.45M$8.55M
Stempoint capital lp467.88K0.52%467.88K$1.63M
Susquehanna fundamental investments202.54K0.01%202.54K$662.31K
Franklin resources92.16K0.00%92.16K$301.36K
Caption management69.60K0.00%69.60K$227.59K

Sold Out

HolderChange
Federated hermes-3.00
Nelson, van denburg & campbell wealth management group-24.00
Opal wealth advisors-100.00
Central trust-100.00
Capital performance advisors llp-545.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20259-94.48%30,187,875-70.98%160.54%8-89.19%--100.00%
Dec 31, 20241615.23%103,747,4872.96%541.93%73-5.19%4441.94%
Sep 30, 202415312.50%100,767,7004.58%532.03%778.45%313.33%
Jun 30, 20241355.47%96,359,00316.04%542.19%7126.79%30-6.25%
Mar 31, 20241284.92%83,042,4715.67%502.27%567.69%3214.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF4.92M2.57%-
Vanguard Total Stock Mkt Idx Inv4.87M2.54%-
Morgan Stanley Insight A4.24M2.23%399.58K
Morgan Stanley Insight4.20M2.19%-47.11K
Morgan Stanley Insight I4.20M2.19%-47.11K
iShares Russell 2000 ETF3.75M1.96%1.84K
MS INVF Global Insight Z2.50M1.31%-
Vanguard Institutional Extnd Mkt Idx Tr2.35M1.23%5.79K
Morgan Stanley Inst Inception I2.13M1.11%-157.50K
Morgan Stanley Inception2.13M1.11%-157.50K

Recent Insider Transactions


DateNameRoleActivityValue
Feb 04, 2025HASTINGS DAVID C Chief Financial OfficerSell$72.83K
Feb 04, 2025Sims Karen Chief Medical OfficerSell$63.52K
Feb 04, 2025McElhaugh Michael J. Interim President & CEOSell$78.10K
Feb 04, 2025Naftzger J. Christopher General Counsel and CCOSell$37.21K
Aug 14, 2024MANCHESTER KEITH S-Sell$32.64K

Insider Transactions Trends


DateBuySell
2025 Q1-4
2024 Q3-1
2024 Q2--
2024 Q1-4
2023 Q3--

ABUS Ownership FAQ


Who Owns Arbutus Biopharma?

Arbutus Biopharma shareholders are primarily institutional investors at 16.26%, followed by 21.89% insiders and 61.85% retail investors. The average institutional ownership in Arbutus Biopharma's industry, Biotech Stocks , is 63.96%, which Arbutus Biopharma falls below.

Who owns the most shares of Arbutus Biopharma?

Arbutus Biopharma’s largest shareholders are Morgan stanley (20.96M shares, 11.93%), Whitefort capital management, lp (13.31M shares, 7.17%), and Blackrock funding, inc. /de (12.94M shares, 6.85%). Together, they hold 25.95% of Arbutus Biopharma’s total shares outstanding.

Does Blackrock own Arbutus Biopharma?

Yes, BlackRock owns 6.58% of Arbutus Biopharma, totaling 11.55M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 35.7M$. In the last quarter, BlackRock increased its holdings by 1.15M shares, a 11.03% change.

Who is Arbutus Biopharma’s biggest shareholder by percentage of total assets invested?

Whitefort capital management, lp is Arbutus Biopharma’s biggest shareholder by percentage of total assets invested, with 21.85% of its assets in 13.31M Arbutus Biopharma shares, valued at 46.44M$.

Who is the top mutual fund holder of Arbutus Biopharma shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Arbutus Biopharma shares, with 2.57% of its total shares outstanding invested in 4.92M Arbutus Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools